FAM111B enhances glycolysis and promotes metastasis of prostate cancer by upregulating LDHA
Qingliu He(Union Hospital), Yifei Xing(Union Hospital), Chuxiong Wang(Union Hospital), Yarong Song(Union Hospital), Zehao Yu(Union Hospital), Haoran Li(Union Hospital), Liang Chen(University at Buffalo, State University of New York), Pu Zhang(Union Hospital), Kang Chen(Wayne State University), Jinyu Chen(Union Hospital), Xuechao Li(Huazhong University of Science and Technology), Lulin Cheng(Union Hospital), Ying Ju(Union Hospital), Yukun Cong(Union Hospital), Fang Lv(Liaoning Normal University)
Cited by 2
Related Papers
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115